Stock Analysis

Al Hammadi Holding Full Year 2023 Earnings: Beats Expectations

SASE:4007
Source: Shutterstock

Al Hammadi Holding (TADAWUL:4007) Full Year 2023 Results

Key Financial Results

  • Revenue: ر.س1.18b (up 4.8% from FY 2022).
  • Net income: ر.س303.3m (up 18% from FY 2022).
  • Profit margin: 26% (up from 23% in FY 2022).
  • EPS: ر.س1.90 (up from ر.س1.61 in FY 2022).
revenue-and-expenses-breakdown
SASE:4007 Revenue and Expenses Breakdown April 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Al Hammadi Holding Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 7.9%. Earnings per share (EPS) also surpassed analyst estimates by 89%.

The primary driver behind last 12 months revenue was the Medical Services segment contributing a total revenue of ر.س950.9m (81% of total revenue). Notably, cost of sales worth ر.س744.2m amounted to 63% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to ر.س111.3m (86% of total expenses). Explore how 4007's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Healthcare industry in Saudi Arabia.

Performance of the Saudi Healthcare industry.

The company's shares are down 9.5% from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for Al Hammadi Holding that you should be aware of before investing here.

Valuation is complex, but we're helping make it simple.

Find out whether Al Hammadi Holding is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.